missing translation for 'onlineSavingsMsg'
Learn More

Anti-Human HLA-DR (L243), Proteintech

Mouse Monoclonal Antibody

£30.00 - £92.00

Specifications

Antigen HLA-DR
Clone L243
Concentration 500 μg/mL
Applications Flow Cytometry
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30235344
View Documents
Proteintech
65218-1-IG-500UG
500 μg
ONLINE EXCLUSIVE PRICE
£99.00
£92.00 / 500µg
Save £7.00
7% Off
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30236667
View Documents
Proteintech
65218-1-IG-100UG
100 μg
ONLINE EXCLUSIVE PRICE
£32.00
£30.00 / 100µg
Save £2.00
6% Off
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

The HLA-DR antibody from Proteintech is a mouse monoclonal antibody generated with human lymphoblastoid b-cell line rpmi 8866 of human HLA-DR. This antibody recognizes human antigen. The HLA-DR antibody has been validated for the following applications: FC analysis.
Specifications

Specifications

HLA-DR
500 μg/mL
Monoclonal
Liquid
RUO
3122
Human lymphoblastoid B-cell line RPMI 8866
Primary
Store at 2-8°C. Stable for one year after shipment.
L243
Flow Cytometry
Unconjugated
Mouse
Human
HLA-DRA1
IgG2a κ
Protein A purification
Flow Antibody
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.